Concepedia

Adjuvant Immunotherapy

Adjuvant Immunotherapy is a form of cancer immunotherapy administered after primary curative-intent treatment, typically surgery, to eliminate residual micrometastatic disease and reduce the risk of tumor recurrence.

1.7K

Publications

135K

Citations

13K

Authors

2.7K

Institutions

Publications per year

2017–2026

620

Parents

Children

Publications

1.7K

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

, , +17

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart, Marion Procter, Brian Leyland‐Jones et al. · New England Journal of Medicine · 2005 · 5.1K citations · Full text

, , +16

Cancer immunotherapy: moving beyond current vaccines

Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text

, , +14

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

, , +17

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · New England Journal of Medicine · 2018 · 1.9K citations · Full text

, , +17

1–5 of 1.7K

Authors

13K

  1. PA
    Paolo A. Ascierto

    Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy

    33 publications · 8.5K citations

    25

    h-index

  2. GV
    Georgina V. Long

    The University of Sydney, Australia

    38 publications · 6.3K citations

    23

    h-index

  3. CR
    Caroline Robert

    Institut Gustave Roussy, France

    25 publications · 5.5K citations

    20

    h-index

  4. CU
    Christian U. Blank

    The Netherlands Cancer Institute, Netherlands

    27 publications · 4.7K citations

    20

    h-index

  5. MS
    Matteo S. Carlino

    Melanoma Institute Australia, Australia

    21 publications · 3.8K citations

    19

    h-index

1–5 of 13K

Institutions

2.7K

  1. Memorial Sloan Kettering Cancer Center

    New York, United States

    41 h-index

    317 publications

    56.5K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    37 h-index

    244 publications

    29.4K citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    36 h-index

    345 publications

    75.4K citations

  4. Institut Gustave Roussy

    Villejuif, France

    35 h-index

    87 publications

    14.8K citations

  5. Harvard University

    Cambridge, United States

    31 h-index

    193 publications

    17.4K citations

  6. Melanoma Institute Australia

    Sydney, Australia

    29 h-index

    173 publications

    21.8K citations

  7. European Institute of Oncology

    Milan, Italy

    29 h-index

    72 publications

    31.8K citations

  8. The Netherlands Cancer Institute

    Amsterdam, The Netherlands

    28 h-index

    228 publications

    38.5K citations

1–8 of 2.7K

Venues

  1. Journal of Clinical Oncology

    151 publications · 10.1K citations

    52

    h-index

  2. Vaccine

    66 publications · 4.2K citations

    38

    h-index

  3. PubMed

    Repository · 151 publications · 5.9K citations

    37

    h-index

  4. Cancer

    37 publications · 2.1K citations

    25

    h-index

  5. Clinical Cancer Research

    25 publications · 2.6K citations

    25

    h-index

1–5